Reliant Pharmaceuticals was preparing for a pending IPO to occur during the fall of 2007. With such a significant event underway, Internal Control over Financial Reporting (ICFR) was top of mind for the company's management team, Board of Directors, and the Internal Audit department. The company was using MS Excel and Word to document its processes and controls - a common, yet fragmented approach, with major concerns relating to version control and ownership. Furthermore the Internal Audit team, along with outside consultants, had identified over 600 key controls for a single location business with no subsidiaries or divisions.
